Aquatic Capital Management’s ClearPoint Neuro CLPT Stock Holding History

Aquatic Capital Management’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$33.3K	Sell	1,866 -87,811	-98%	-$1.1M	﹤0.01%	1174
2026 Q1	$816K	Buy	+89,677	New	+$1.13M	0.02%	612
2025 Q3	–	Sell	-3,618	Closed	-$43.2K	–	1425
2025 Q2	$43.2K	Sell	3,618 -1,774	-33%	-$22.3K	﹤0.01%	1152
2025 Q1	$64.1K	Buy	+5,392	New	+$83.8K	﹤0.01%	1120
2023 Q1	–	Sell	-3,200	Closed	-$27K	–	1326
2022 Q4	$27K	Buy	3,200 +1,200	+60%	+$11.4K	﹤0.01%	1121
2022 Q3	$21K	Buy	+2,000	New	+$26.4K	﹤0.01%	991

Other funds holding CLPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MCO

MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

CFM

Compass Financial Management Tampa, Florida $829M AUM

Aquatic Capital Management's CLPT Position: Q2 2026 in Review

Aquatic Capital Management reduced its ClearPoint Neuro (CLPT) stake by 98% in Q2 2026, selling an estimated $1.1M and leaving 1,866 shares worth $33.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1174.

Aquatic Capital Management first reported a position in CLPT in Q3 2022 and has held it in 6 quarters since. The position peaked at $816K in Q1 2026. 129 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

Aquatic Capital Management held 1,866 shares of ClearPoint Neuro worth $33.3K as of Q2 2026.
Aquatic Capital Management sold 87,811 ClearPoint Neuro shares in Q2 2026, an estimated $1.1M.
ClearPoint Neuro made up ﹤0.01% of Aquatic Capital Management's portfolio in Q2 2026, its #1174 holding.
Aquatic Capital Management first reported a position in ClearPoint Neuro in Q3 2022 and has held it in 6 quarters since.
Aquatic Capital Management's ClearPoint Neuro position peaked at $816K in Q1 2026.
129 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.